Clinical Trials Directory

Trials / Unknown

UnknownNCT03522792

Neurotensin - an Important Regulator of Appetite in Humans?

The Effect of Neurotensin on Appetite, Food Intake, Blood Glucose Regulation, Hormone Secretion, and the Degradation of Neurotensin in Vivo

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
18 (estimated)
Sponsor
University of Copenhagen · Academic / Other
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Neurotensin (NT) is a gut peptide released postprandially from the small intestine. It is known to exert a range of enterogastrone effects and in animal models it reduces food intake when administered by parenteral routes. This study investigates whether the anorexic effects of NT suggested by animal studies can be translated.

Conditions

Interventions

TypeNameDescription
OTHERNeurotensinIntravenous infusion of neurotensin
OTHERSalineIntravenous infusion of saline
OTHERAd libitum mealParticipants will be served a large meal serving. They will be instructed to eat until they do not feel hungry anymore.
OTHERLiquid mealA standardized mixed liquid meal will be ingested to stimulate endogenous peptide hormone release

Timeline

Start date
2018-01-05
Primary completion
2019-05-01
Completion
2019-12-01
First posted
2018-05-11
Last updated
2019-11-12

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03522792. Inclusion in this directory is not an endorsement.